bpc-157 clinical trials 2026 Hits a Milestone: The First Controlled Human Trial Is Now Recruiting | PeptIQ Blog Best BPC-157 Oral Supplements: Prohealth's
Description
Previously indicated for Infantile Spasms, the added Sabril indication is for: Refractory Complex Partial Seizures as adjunctive therapy in patients 2 years of age and older who have responded inadequately to several alternative treatments
Moreover, we also observed a significant decrease in I max
It is also advised to avoid alcohol for better treatment, as consumption of alcohol decreases the absorption of vitamin B from the gastrointestinal tract
[DOI] [PubMed] [Google Scholar] 260
